Bottom line
What does HRTS hold?
HRTS held 45 positions as of May 31, 2026. Its largest holding is Eli Lilly & Co at 11.52% of the fund, and the top 10 positions add up to 49.1%. By asset type it is 99% stocks, 1% cash & short-term funds.
Updated Jul 29, 2026
HRTS top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co LLY | Stocks | 11.52% | $6.0M |
| 2 | UnitedHealth Group Inc UNH | Stocks | 5.24% | $2.7M |
| 3 | Novo Nordisk A/S NOVOB | Stocks | 5.24% | $2.7M |
| 4 | Roche Holding AG RHHBY | Stocks | 4.50% | $2.3M |
| 5 | Merck & Co Inc MRK | Stocks | 4.27% | $2.2M |
| 6 | AstraZeneca PLC AZN | Stocks | 4.00% | $2.1M |
| 7 | Thermo Fisher Scientific Inc TMO | Stocks | 3.97% | $2.1M |
| 8 | Johnson & Johnson JNJ | Stocks | 3.59% | $1.9M |
| 9 | Gilead Sciences Inc GILD | Stocks | 3.43% | $1.8M |
| 10 | Novartis AG NOVN | Stocks | 3.38% | $1.8M |
| 11 | Revolution Medicines Inc RVMD | Stocks | 3.33% | $1.7M |
| 12 | Vertex Pharmaceuticals Inc VRTX | Stocks | 2.93% | $1.5M |
| 13 | Danaher Corp DHR | Stocks | 2.66% | $1.4M |
| 14 | Abbott Laboratories ABT | Stocks | 2.61% | $1.4M |
| 15 | Bridgebio Pharma Inc BBIO | Stocks | 2.59% | $1.3M |
| 16 | Cytokinetics Inc CYTK | Stocks | 2.52% | $1.3M |
| 17 | AbbVie Inc ABBV | Stocks | 2.40% | $1.2M |
| 18 | Bristol-Myers Squibb Co BMY | Stocks | 2.09% | $1.1M |
| 19 | Teva Pharmaceutical Industries TEVA Teva Pharmaceutical Industries Ltd |
Stocks | 2.06% | $1.1M |
| 20 | Dexcom Inc DXCM | Stocks | 1.92% | $996.4K |
| 21 | Amgen Inc AMGN | Stocks | 1.91% | $992.2K |
| 22 | Medtronic PLC MDT | Stocks | 1.88% | $974.5K |
| 23 | Edwards Lifesciences Corp EW | Stocks | 1.75% | $906.9K |
| 24 | McKesson Corp MCK | Stocks | 1.71% | $888.0K |
| 25 | Regeneron Pharmaceuticals Inc REGN | Stocks | 1.67% | $865.6K |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 29, 2026